Eden Biodesign, one of the UK's leading contract bio manufacturers, is advancing towards establishing its US operation and is shoring up its technical expertise with the appointment of Michael Faughnan.
Faughnan joins as new business development director of the company's US subsidiary, Eden Biodesign Inc. He will be supporting Dr Roger Lias, president of Eden Biodesign, Inc. and group commercial director with responsibilities for North American Business Development activities.
Located in Southern California, Faughnan brings over 14 years of experience in successfully aiding clients in accelerating their biopharmaceutical products in to and through clinical development and to commercial launch.
Lias said: "Michael brings tremendous experience and will be an invaluable asset as we continue to build our US infrastructure and expand our services to clients in the North American market."
